Mukherjee Avinaba, Khuda-Bukhsh Anisur Rahman
Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.
J Pharmacopuncture. 2015 Mar;18(1):19-26. doi: 10.3831/KPI.2015.18.002.
Quercetin, a flavonoid compound, has been reported to induce apoptosis in cancer cells, but its anti-inflammatory effects, which are also closely linked with apoptosis, if any, on non-small-cell lung cancer (NSCLC) have not so far been critically examined. In this study, we tried to determine if quercetin had any demonstrable anti-inflammatory potential, which also could significantly contribute to inducing apoptosis in a NSCLC cell line, A549.
In this context, several assays, including cytotoxicity, flow cytometry and fluorimetry, were done. Gene expression was analyzed by using a western blot analysis.
Results revealed that quercetin could induce apoptosis in A549 cells through mitochondrial depolarization by causing an imbalance in B-cell lymphoma 2/ Bcl2 Antagonist X (Bcl2/Bax) ratio and by down-regulating the interleukine-6/signal transducer and activator of transcription 3 (IL-6/STAT3) signaling pathway. An analysis of the data revealed that quercetin could block nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity at early hours, which might cause a down-regulation of the IL-6 titer, and the IL-6 expression, in turn, could inhibit p-STAT3 expression. Down-regulation of both the STAT3 and the NF-κB expressions might, therefore, cause down-regulation of Bcl2 activity because both are major upstream effectors of Bcl2. Alteration in Bcl2 responses might result in an imbalance in the Bcl2/Bax ratio, which could ultimately bring about mitochondria mediated apoptosis in A549 cells.
Overall, the finding of this study indicates that a quercetin induced anti-inflammatory pathway in A549 cells appeared to make a significant contribution towards induction of apoptosis in NSCLC and, thus, may have a therapeutic use such as a strong apoptosis inducer in cancer cells.
槲皮素是一种黄酮类化合物,据报道可诱导癌细胞凋亡,但其对非小细胞肺癌(NSCLC)的抗炎作用(若有的话),而这也与凋亡密切相关,迄今为止尚未得到严格检验。在本研究中,我们试图确定槲皮素是否具有任何可证明的抗炎潜力,这也可能对诱导NSCLC细胞系A549凋亡有显著作用。
在此背景下,进行了包括细胞毒性、流式细胞术和荧光测定法在内的多项检测。通过蛋白质印迹分析来分析基因表达。
结果显示,槲皮素可通过导致B细胞淋巴瘤2/Bcl2拮抗剂X(Bcl2/Bax)比值失衡以及下调白细胞介素-6/信号转导和转录激活因子3(IL-6/STAT3)信号通路,引起线粒体去极化,从而诱导A549细胞凋亡。数据分析表明,槲皮素可在早期阻断活化B细胞核因子κB(NF-κB)活性,这可能导致IL-6滴度下调,而IL-6表达反过来又可抑制p-STAT3表达。因此,STAT3和NF-κB表达的下调可能导致Bcl2活性下调,因为两者都是Bcl2的主要上游效应器。Bcl2反应的改变可能导致Bcl2/Bax比值失衡,最终导致A549细胞中线粒体介导的凋亡。
总体而言,本研究结果表明,槲皮素在A549细胞中诱导的抗炎途径似乎对NSCLC凋亡诱导有显著贡献,因此可能具有治疗用途,例如作为癌细胞中强大的凋亡诱导剂。